The HERA W10 Elite ultrasound platform provides enhanced visualization features and artificial intelligence (AI)-aided measurement capabilities.
Could the HERA W10 Elite reinvent ultrasound imaging in obstetrics and gynecology care?
The newly launched ultrasound system offers 2D and 3D visualization of microcirculatory and slow blood with the Advanced MV-Flow™ feature and a large organic light-emitting diode (OLED) display that provides improved characterization of diverse ultrasound images, according to Samsung, the manufacturer of the HERA W10 Elite system.
Samsung said the HERA W10 Elite also has HeartAssist™, an artificial intelligence (AI)-enhanced feature that provides automated measurement views to facilitate diagnosis of the fetal heart.
(Editor’s note: For related content, see “Adjunctive AI Software for Cardiac Ultrasound Gets FDA Nod” and “Emerging Trends in AI, Ultrasound and OB/GYN Care.”)
Other planned features, pending 510(k) clearance from the Food and Drug Administration (FDA), include a new EV2-12 transducer that allows imaging of the fetal heart and brain starting at eight weeks and Biometry Assist™, which allows one-click measurement of fetal growth parameters.
“Women’s health is a fast-growing field that requires state-of-the-art equipment for patient care. The HERA W10 Elite will bring visionary change to obstetrics and gynecology with sophisticated image processing and an ergonomic-friendly design,” noted Tracy Bury, Women’s Health Ultrasound Business Leader with Boston Imaging, the United States headquarters for Samsung’s digital radiography and ultrasound business.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.